Science Community Divided On Stewart-Feder Shutdown

Reaction in the science community has been impassioned and partisan over the April 9 decision at the National Institutes of Health to "reassign" scientists Walter Stewart and Ned Feder to new posts, effectively ending their independent scientific integrity research at the institutes. Stewart and Feder's self- initiated investigative work, conducted over the past decade, has sparked intense controversy at times and has been central to a number of high-profile misconduct cases. The pair's probe

Written byFranklin Hoke
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Reaction in the science community has been impassioned and partisan over the April 9 decision at the National Institutes of Health to "reassign" scientists Walter Stewart and Ned Feder to new posts, effectively ending their independent scientific integrity research at the institutes. Stewart and Feder's self- initiated investigative work, conducted over the past decade, has sparked intense controversy at times and has been central to a number of high-profile misconduct cases.

The pair's probes often have forced professional science to confront troubling issues. Some scientists have called Stewart and Feder's questioning improper, ill-informed, and destructive to both science and individual scientists. But others have welcomed the debates as part of a necessary, if often trying, process to renew and strengthen the scientific method, which they see as broadly undermined by considerations other than the pursuit of scientific truth.

On the first day of their forced reassignment, May 10, the two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies